Status:
WITHDRAWN
Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors
Lead Sponsor:
Capital Medical University
Conditions:
Brain Tumor, Pediatric
Eligibility:
All Genders
3-18 years
Brief Summary
To investigate the effect of radiotherapy on peripheral blood immune cell composition and function in pediatric malignant brain tumor patients.
Eligibility Criteria
Inclusion
- Age from 3 to 18
- To be diagnosed with malignant brain tumors
- To eligible for radiation therapy
- Karnofsky performance status ≥ 70
- No prior radiation exposure
- Informed consent signed for blood sample collection and used for research purpose
Exclusion
- Patients had received radiotherapy previously.
- Patients who had no histological diagnosis
- Patients who do not wish to participate
- Patients with infections
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04019470
Start Date
February 1 2019
End Date
May 31 2022
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Shijitan Hospital Cancer Center
Beijing, China